Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum vs Calcium Carbonate on FGF23 in Hemodialysis
NCT01845090Phase 4Unknown
- Sponsor
- Lotung St. Mary's Hospital
- Start
- Aug 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lanthanum carbonate in hyperphosphatemia (2 arms), sponsored by Lotung St. Mary's Hospital. Primary endpoint: Serum level of fibroblast growth factor 23 at 6 months. Status: unknown.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01845090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845090.